She says she was originally declared NED but if I remember correctly, the surgical margins were not clear.
Ok so another liver growth and some growth in the dura part of the brain. So she declined chemo again until ordered by other specialists to do it.
I can't believe Eamon is asking about alternative treatments. When did alternative stuff ever did anything? They are proven again and again that real medicine helps despite their stupid refusal. I don't understand these two. And bang in the middle of the video - a betterhelp sponsorship. You couldn't make this tit up. I doubt they would ever use betterhelp themselves but anything for money. They come back to youtube when they need to cash in again. Frolicking around the world without any care is not cheap. They are already talking about Mexico.
I watched the beginning update, but dropped off at the other life updates about the tea, so don't know what was said after that.
What troubled me, well, a couple things.
Firstly, didn't her doctor advise her against pregnancy at the time she got pregnant? I thought her doctor was most displeased about that.
Secondly, I was troubled listening to her speak, as if she didn't understand how her cancer could have been progressing when she had been doing so many healthful lifestyle measures, as if her cancer should have been impacted by all her meditations, etc.
But, then I thought perhaps there was meaningful information on this that I wasn't aware of. I'm not referring to "alternatives" such as those in the Mexico clinics, just Bec's general holistic measures that she's mentioned.
So, I asked AI. Please note it has been known to present inaccuracies, and I did not go through every single link it provided.
I did find some information that alternative holistic changes or measures might impact disease course, and some may improve patient well-being levels (but that's different than cancer outcomes).
For example, exercise compared to sedentary lifestyles did appear to have an effect on cancer outcomes Studies into psychosocial supports interventions did appear to trend towards a modest increase in longevity to 3.9 months. Other lifestyle measures may have some impact as well.
From AI (with links):
Q: Is there any evidence that any holistic or alternative treatments improve cancer outcomes? list verified sources and links
A: No alternative therapies that replace conventional treatment improve cancer outcomes; in fact, replacing standard care with alternative medicine is associated with significantly higher mortality and lower 5-year survival rates. However, complementary therapies used alongside conventional treatment show evidence of improving quality of life, managing symptoms, and in some cases, modestly supporting survival when used as adjuncts.
Risks of Replacing Conventional Treatment
Replacing standard oncology care with alternative therapies is dangerous and linked to worse survival.
Higher Mortality: A study of patients with nonmetastatic breast, lung, colorectal, or prostate cancer found that those who replaced conventional therapy with alternative treatments had a 5-year survival rate of 55%, compared to 78% for those receiving conventional treatment (Hazard Ratio 2.21).
Increased Risk of Death: The same study indicated that alternative medicine use was independently associated with a 2.50 times greater risk of death (95% CI 1.88–3.27) compared to conventional care.
Professional Stance: Major organizations like Worldwide Cancer Research and the American Cancer Society state there is no scientific proof that alternative therapies can cure cancer or slow its growth, and using them instead of conventional treatment can be damaging.
Evidence for Complementary Therapies (Adjunctive Use)
When used as complementary (adjunctive) therapies, several interventions have robust evidence for improving patient-reported outcomes and symptom management, though they do not directly cure cancer.
Acupuncture: Has the strongest evidence for managing chemotherapy-induced nausea, cancer-related pain, and fatigue.
Exercise: Aerobic and resistance training are recommended by ASCO and show a 20–40% reduction in cancer-specific mortality in physically active survivors compared to sedentary counterparts.
Repurposed Drugs & Supplements:
Metformin, Statins, and Cimetidine: Show Tier 1 evidence for survival benefits in specific contexts (e.g., colorectal cancer).
Mistletoe (Iscador): Multiple RCTs show consistent quality-of-life improvements during chemotherapy.
Curcumin: Under preliminary research for therapeutic potential, but no reputable organization supports claims that it can cure cancer.
Mind-Body Therapies: Yoga, meditation, and music therapy show measurable clinical benefits in reducing anxiety and improving fatigue.
Verified Sources and Links
Memorial Sloan Kettering Cancer Center: Alternative Cancer Treatments: The Science vs. The Hype
Uncover the truth about alternative medicine in cancer care. Learn how acupuncture, herbs, and supplements can complement treatment—and what to avoid.
www.mskcc.org
NCCIH (National Center for Complementary and Integrative Health): Cancer and Complementary Health Approaches
Safety and effectiveness information on complementary health approaches for cancer prevention, treatment, and symptom management.
www.nccih.nih.gov
Worldwide Cancer Research: Position on Alternative Cancer Therapies
There is no scientific proof that alternative therapies can cure cancer, and it can be dangerous to use them instead of conventional treatments. However, we know that facing a cancer diagnosis can be overwhelming and people may look for alternative treatments to help them feel better. Here we...
www.worldwidecancerresearch.org
PMC (PubMed Central): Evidence-Based Perspectives on Complementary and Alternative Medicine in Cancer Treatment
Cancer is a leading cause of death worldwide with considerable physical, psychological and socioeconomic impact. In parallel to traditional treatments such as chemotherapy, radiotherapy, surgery and immunotherapy, patients with cancer have ...
pmc.ncbi.nlm.nih.gov
JAMA Oncology: Use of Alternative Medicine for Cancer and Its Impact on Survival
Mayo Clinic: Alternative cancer treatments: 11 options to consider
Macmillan Cancer Support: Alternative therapies
Q: I don't see any links or support for your comment that "complementary therapies used alongside conventional treatment show evidence... [of] modestly supporting survival when used as adjuncts."
A: You're right to push back. I overstated the evidence in my previous answer. Here's the honest breakdown:
What's actually supported
Exercise/physical activity — the strongest evidence for a survival benefit from a non-pharmacological adjunctive intervention:
A 2025 meta-analysis of 151 cohorts (~1.5 million patients) found post-diagnosis physical activity associated with 24–31% lower cancer-specific mortality across breast, lung, prostate, and colorectal cancers.
A 2026 meta-analysis of 13 RCTs (n=3,282) found a 26% reduction in all-cause mortality (HR 0.74, 95% CI 0.63–0.87).
A 2026 meta-analysis of RCTs found significant improvements in overall survival (HR 0.77) and disease-free survival (HR 0.83).
However, exercise is a lifestyle intervention, not what most people mean by "complementary/alternative therapy."
Psychosocial interventions — a 2026 meta-analysis of 32 RCTs (n=5,704) found a small but robust survival benefit (HR 0.80, 95% CI 0.71–0.90) when provided alongside medical treatment. This is the closest thing to a "complementary therapy" with RCT-level survival evidence.
What I got wrong
Metformin — I called this "Tier 1 evidence for survival benefits." That was incorrect. A 2026 meta-analysis of 19 RCTs (n=3,502) found no significant improvement in OS or PFS (OS HR 1.08, 95% CI 0.90–1.30; p=0.41). The largest phase 3 RCT for breast cancer also found no benefit. The earlier observational signals have not been confirmed by RCTs.
Statins — The apparent survival associations come from retrospective observational studies (SEER-Medicare, etc.), not RCTs. There's significant heterogeneity and no randomized confirmation. This is not "Tier 1."
Mistletoe — Evidence is for quality of life, not survival. I conflated the two.
Bottom line
The claim that complementary therapies "modestly support survival" is not well-supported for the CAM interventions people typically mean (herbs, supplements, energy therapies, etc.). The two exceptions with RCT-level evidence are exercise (a lifestyle intervention) and psychosocial interventions (counseling, stress reduction). My previous framing was too generous.
Sources
Exercise RCT meta-analysis (2026): PubMed
Exercise comprehensive meta-analysis (2025): PubMed
Psychosocial interventions meta-analysis (2026): ResearchGate
A preregistered systematic review, meta-analysis, and multiverse meta-analysis of 32 RCTs (5704 patients) shows that psychosocial interventions consistently prolong cancer survival and clarifies sources of prior inconsistent findings.
www.nature.com
Metformin RCT meta-analysis showing NO OS/PFS benefit (2026): Frontiers in Oncology
ObjectiveThe primary objective is to assess metformin’s impact on progression free survival (PFS), overall survival (OS), and overall response rates (ORR). S...
www.frontiersin.org
Metformin RCT failure review (2023): Diabetes Care
Statins observational meta-analysis (2018): PubMed
CM use and survival in metastatic cancer (2022, observational): PMC
Complementary medicines (CM) are frequently used by patients with cancer. Controversy exists over the effectiveness and risk that CM may add to conventional cancer therapy. The incidence of CM use among patients enrolled in phase III clinical trials ...
pmc.ncbi.nlm.nih.gov
Q: Besides exercise noted above, do any lifestyle or dietary changes improve or alter cancer outcomes?
A: Yes — a few lifestyle factors beyond exercise have real evidence, but the strength and type of evidence varies considerably.
1. Smoking cessation (strongest evidence)
This is the single most impactful lifestyle change. A 2024 JAMA Oncology study found a 22–26% reduction in cancer-related mortality among patients who quit within 3 months of tobacco treatment, with the best benefit when treatment started within 6 months of diagnosis. For lung cancer specifically, a meta-analysis of 25 studies (n=17,584) found a 26% lower risk of death (aHR 0.74, 95% CI 0.68–0.81).
JAMA Oncology 2024 – Early Intervention Smoking Cessation
Cancers 2025 – Meta-analysis of quitting at diagnosis (lung)
Annals of Internal Medicine – Prospective cohort (lung)
2. Dietary pattern quality (consistent observational evidence)
Multiple meta-analyses of cohort studies find that higher adherence to healthy dietary patterns (Mediterranean, DASH, prudent) is associated with ~20–25% lower all-cause mortality among cancer survivors:
A 2025 meta-analysis (98 studies, ~1.5M patients) found the Healthy Eating Index diet associated with reduced cancer-specific mortality (pooled log HR −0.22, p<0.001).
A 2023 meta-analysis found prudent/healthy patterns associated with 22% lower all-cause mortality (HR 0.78), while Western/unhealthy patterns were associated with 48% higher mortality (HR 1.48).
For colorectal cancer specifically, a 2025 JNCI meta-analysis found prudent dietary patterns associated with 36% lower CRC-specific mortality (RR 0.64).
Important caveat: These are all observational cohort studies, not RCTs. Confounding (healthy-user bias, socioeconomic factors) cannot be excluded. No RCT has yet demonstrated that a dietary intervention improves cancer survival.
Medicina 2025 – Lifestyle modifications meta-analysis
Nutrients 2023 – Post-diagnosis dietary patterns meta-analysis
JNCI 2025 – CRC post-diagnosis dietary factors
Nutrients 2023 – Updated dietary indices meta-analysis
3. Alcohol reduction (harm reduction, not a "benefit")
Heavy alcohol use is consistently associated with increased cancer mortality (HR ~1.21–1.27). The old "J-shaped" protective curve for moderate drinking appears to be an artifact of "sick quitter" bias — when lifetime abstinence history is accounted for, even light drinking shows increased cancer mortality in a dose-dependent manner. The actionable takeaway: reducing heavy drinking likely improves outcomes, but no evidence that moderate drinking is protective.
JAMA Network Open 2026 – REGARDS study
Background Cancer prevention strategies often focus on behavior change such as increased screening, smoking cessation, and healthy diets. Recently, enthusiasm for addressing alcohol as a significant cancer risk factor has gained attention. Using a large, population-based cohort, we sought to...
link.springer.com
Scientific Reports 2021 – Low-level alcohol and cancer mortality
The effect of light-to-moderate alcohol consumption on cancer risk remains controversial. We examined the association between low-level alcohol consumption and cancer mortality. A cohort study included 331,984 Korean adults free of cancer at baseline who underwent a comprehensive health checkup...
www.nature.com
4. Obesity / weight (mixed and cancer-specific)
A 2021 meta-analysis of 203 studies (n=6.3M) found obesity associated with 14% higher overall mortality and 17% higher cancer-specific mortality across cancers overall, but paradoxically better survival in lung, renal cell, and melanoma. Weight loss in already-diagnosed patients is associated with worse outcomes (likely reverse causation from advanced disease). This is not a clear actionable intervention.
JAMA Network Open 2021 – Obesity and survival meta-analysis
5. Caloric restriction / intermittent fasting (insufficient evidence)
Despite strong preclinical data, no human RCT has shown improved cancer outcomes from caloric restriction or intermittent fasting. A 2022 review explicitly concludes "there is presently little evidence that intermittent fasting... can enhance cancer outcomes." A 2026 review similarly notes that improvements in risk factors "should not be taken as proof of a reduced risk of cancer."
Frontiers in Oncology 2022 – Fasting and cancer narrative review
Emerging evidence suggests that fasting could play a key role in cancer treatment by fostering conditions that limit cancer cells' adaptability, survival, and growth. Fasting could increase the effectiveness of cancer treatments and limit adverse ...
pmc.ncbi.nlm.nih.gov
Nutrients 2026 – From Fasting to Caloric Restriction
The honest bottom line: smoking cessation is the only non-exercise lifestyle change with robust, large-scale evidence of improved cancer survival. Dietary quality shows consistent observational associations but no causal proof. Fasting and caloric restriction remain unproven in humans.